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ABSTRACT
In recent years, the consumption and use of dietary supplements containing concentrated phytochemicals (e.g. flavonoids) increased 
dramatically. Flavonoids, as foreign compounds (xenobiotics), have great potential to modulate the activity of cytochrome P450s 
(CYPs), xenobiotic-metabolizing enzymes involved in the activation and detoxification of food and environmental carcinogens. Thus, 
the aim of this study was to investigate the effects of model glycosylated and deglycosylated flavonoids on CYPs in rat liver and small 
intestine, as the two main organs responsible for xenobiotic metabolism, after p.o. administration by gastric gavages. The effects of 
two glycosylated flavonoids (isoquercitrin, rutin) and their aglycone (quercetin) on CYPs were determined using Western blotting 
technique and specific activity assays with alkyl-resorufin derivatives. In liver microsomes, a considerable increase of all the measured 
marker activities (EROD, MROD, PROD) was observed only after isoquercitrin treatment. To evaluate the effects of flavonoids on CYPs 
along small intestine, the tissue was dissected into proximal (near pylorus), middle and distal parts. Of all the tested compounds, 
isoquercitrin was the most efficient CYP inducer, namely in the middle part of small intestine. Obtained data demonstrate the dif-
ferent effects of flavonoid glycosides and aglycone on CYP expression in rat liver and small intestine. Since these phytochemicals 
are xenobiotics, and thus they can increase the human risk of cancer development, their consumption in large quantities should be 
carefully considered. 
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P450s (CYPs), monooxygenases metabolizing xenobiotics 
(e.g. drugs, carcinogens), play the most prominent role. 
Since phytochemicals are foreign compounds (xenobiotics), 
their consumption in large quantities should be carefully 
considered. Further, potential dietary supplement-drug and 
food-drug interactions, leading to an overdose or the loss of 
the drug therapeutic effects, have been reported (Jang et al., 
2004; Morris and Zhang, 2006). Beside these interactions, 
the negative properties of these dietary supplements may 
have their origin in: (i) their own toxicity, (ii) metabolic con-
version into cytotoxic or mutagenic agents, (iii) induction 
of carcinogen activating enzymes, and (iv) effect on human 
microflora (Hodek et al., 2009).
Biological benefits of flavonoids depend on their 
bioavailability after oral ingestion. In general, flavonoids 
are metabolized mainly in liver and intestines. Natural 
flavonoids usually occur as β-glycosides that are relatively 
hydrophilic and thus do not diffuse passively across biologi-
cal membranes. Up to now, various studies have been car-
ried out to obtain pharmacological data in order to elucidate 
the absorption, metabolism and disposition of flavonoids. 
However, some of the results are controversial, and the 
complexity of the delivery process from the administration 
Introduction
According to the World Health Organization statistics, 
cancer is one of the leading causes of death in the human 
population worldwide for more than 50 years. Moreover, 
colorectal and gastrointestinal tract cancer are one of the 
main types of cancer leading to overall cancer mortality. 
Prevention consisting in a healthy lifestyle and a natural 
di et  is  sugg ested  to  be  o n e  o f  th e  main  a p p r oa ch es  to  
reduce cancer risk. In recent years, the consumption and 
use of dietary supplements containing concentrated phy-
tochemicals increased dramatically. Flavonoids present 
in foods (fruits, vegetables, herbs, beverages) and dietary 
supplements have the greatest potential to modulate activ-
ity of xenobiotic-metabolizing enzymes (Hodek et al., 2002). 
Among proteins interacting with flavonoids, cytochrome 
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si te to th e targ et o rgans, possib ly via r ecep to rs, mak es  
generalization of flavonoid metabolism hardly possible. It 
has been suggested, that glycoside transporters (Gee et al., 
1998), β-glucosidases (Day et al., 1998), colon microflora 
(Parkar et al., 2008, Atkinson et al., 2005) and conjugation of 
aglycones to glucuronides are the main metabolic pathways 
of flavonoids in small intestine and liver (Zhang et al., 2007).
The aim of this study is to examine the effects of glyco-
sylated flavonoids, isoquercitrin and rutin, on cytochrome 
P450 expression in comparison with their aglycone, querce-
tin, in rat liver and small intestine, as the two main organs 
responsible for xenobiotic metabolism. 
Material and Methods
Chemicals
β-Naphthoflavone, quercetin dihydrate, rutin hydrate 
(quercetin-3-rutinoside), NADPH, bicinchoninic acid, 
resorufin, 7-ethoxyresorufin, 7-methoxyresorufin, 7-pent-
oxyresorufin, and anti-chicken IgG alkaline phosphatase 
conjugate, BCIP/NBT tablets were purchased from Sigma 
Chemical Co., (St. Louis, MO). Isoquercitrin (quercetin-
3-β-D-glucoside, purity 98.2%) was prepared by Dr. Křen. 
Specific chicken anti-CYP1A1/2 and anti-CYP2B1/2 
antibodies were prepared by Dr. Hodek. All other chemicals 
were purchased from standard commercial sources and 
were of the highest quality available.
Animal treatment and preparation of microsomes
All studies with rats were carried out in accordance with 
guidelines of the Ethical Committee of Faculty of Science. 
Male Wistar rats ( 150 g) obtained from AnLab, Czech  
Republic, were housed in groups of 3 in wire cages at 22 °C 
with a 12 h light/dark period and ad libitum diet (ST-1 diet 
from Velaz, Czech Republic) and water access. The tested 
chemopreventive compounds (60 mg/kg body weight) were 
administered p.o. by gastric gavages, dissolved in sunflower 
oil (1 ml), daily for 5 consecutive days. The control group 
was treated with 1 ml of sunflower oil only. The treated rats 
were fasted overnight and, twenty-four hours after the last 
treatment, they were sacrificed. Microsomes were prepared 
from sections of small intestine and whole liver, immediately 
after sacrificing the rats, as described previously (Křížková 
et al., 2008). Tissues from 3 rats were pooled for each 
microsomal preparation. Small intestine was removed circa 
2 cm under the stomach, divided into three parts (proximal 
near pylorus, middle, distal), each approximately 20  cm 
long. Microsomes from animals pretreated with rutin were 
available only from proximal and distal parts. Microsomal 
fractions were stored at –80 °C before use.
Determination of protein concentration and Western blot analysis
Protein concentration in microsomes was measured accord-
ing to Smith et al. (1985) using bicinchoninic acid with 
bovine serum albumin as the standard. The CYP1A and 
CYP2B were detected by Western blotting on Immobilon-P 
membrane (Millipore, Bedford, MA) using specific chicken 
anti-CYP1A1/2 and anti-CYP2B1/2 antibodies. Since the 
content of cytochrome P450s in small intestine is lower 
compared to liver microsomes, the samples used for SDS-
electrophoresis (30  μg protein/well, 8% polyacrylamide 
gel) and following Western blotting analysis were twice as 
concentrated as the ones from liver (15  μg protein/well). 
Visualization was performed using an anti-chicken IgG 
alkaline phosphatase-conjugated antibody and BCIP/NBT 
tablets containing 10 mg substrate for alkaline phosphatase. 
Enzyme assays
The CYP activity of microsomes was characterized by use of 
alkyl-resorufin derivatives. 7-Ethoxyresorufin-O-deethylase 
(EROD), 7-methoxyresorufin-O-demethylase (MROD) and 
7-pentoxyresorufin-O-depentylase (PROD) activity assays 
were determined according to the method described by 
Burke and Mayer (1974). Formation of the resorufin was con-
tinuously measured for 10 minutes at room temperature by 
monitoring its fluorescence (excitation and emission wave-
lengths of 530 and 585 nm, respectively). The dealkylation 
rate was estimated on the basis of a resorufin standard curve. 
Results
Eff  ects of fl  avonoids on CYP enzyme activities 
in liver and small intestine
Two glycosylated flavonoids (isoquercitrin, rutin), and 
their aglycone, quercetin (Figure 1), were tested for their 
effects on CYP activities in liver and small intestine 
after p.o. administration. In respect of liver microsomes, 
Figure 2A illustrates EROD, MROD and PROD activities 
quercetin isoquercitrin rutin
Figure 1. Structure of tested fl  avonoids.203
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for CYP1A1, CYP1A2 and CYP2B1/2, respectively. In all 
cases, isoquercitrin increased significantly CYP activities, 
with the highest increase being in PROD activity, more than 
3-times compared to untreated rats. Rutin administration 
also enhanced all measured specific activities, in the same 
manner but to a lesser extent than isoquercitrin.
For comparison between two organs highly exposed to 
xenobiotics (liver and small intestine), the effects of flavo-
noids on CYPs in small intestine dissected into three parts 
were also studied. In small intestine, an identical trend of 
quercetin and isoquercitrin effects on CYP activities was 
observed (Figure 3A). Surprisingly, the highest increase of 
EROD and PROD activity was determined in the middle 
part of the small intestine. All the tested compounds did 
not affect MROD activity compared to untreated rats (data 
not shown). Results from the administration of a synthetic 
flavonoid, β-naphthoflavone (data not shown), showed the 
same trend as in case of rutin treatment.
Western blot analysis of CYPs expression in small intestine and liver
To confirm data from CYP marker activities, we exam-
ined the levels of CYPs protein using Western blotting 
technique. In respect of liver microsomes, the results of 
Western blot detection of CYPs are shown in Figure 2B. 
A strong induction of CYP1A1 was observed only after 
isoquercitrin treatment, which along with rutin also 
induced CYP1A2. On the other hand, a considerable 
increase in CY2B1/2 expression at the protein level was 
not demonstrated. 
A l t h o u g h  C Y P s  i n  e x t r a h e p a t i c  t i s s u e s  a r e  s e v e r a l  
times less abundant than in liver, we succeeded in detect-
ing CYP1A1 and CYP2B1 in small intestine (Figure 3B). 
Isoquercitrin caused strong induction of both detected 
CYPs, CYP1A1 and CYP2B1, in the middle part of small 
intestine. However, in the proximal part, a marked induc-
tion of CYP2B1 was detected in rats pretreated with quer-




Figure 2. (A) Eff  ects of fl  avonoids on EROD, MROD and PROD activity of CYP1A1, CYP1A2 and CYP2B1/2, respectively, in rat liver microsomes after 
dietary exposure to fl  avonoids (60 mg/kg body weight) for 5 days. Bars represent the means ± SD of 3 determinations. (B) Immunodetection of 
CYP1A1, CYP1A2 and CYP2B1/2 in liver microsomes. Electrophoresed microsomal proteins (15 μg) were transferred to Immobilon-P membrane and 
probed with antibody against CYP1A1, CYP1A2 and CYP2B1/2.
CYP1A1 CYP2B1/2 A
B
Figure 3. (A) Eff  ects of fl  avonoids on EROD and PROD activity of CYP1A1 and CYP2B1/2, respectively, in the proximal (P), middle (M) and distal (D) 
part of rat small intestine after dietary exposure to fl  avonoids (60 mg/kg body weight) for 5 days. Bars represent the means ± SD of 3 determinations. 
(B) Immunodetection of CYP1A1 and CYP2B1/2 in the proximal (P), middle (M) and distal (D) part of rat small intestine. Electrophoresed microsomal 
proteins (30 μg) were transferred to Immobilon-P membrane and probed with antibody against CYP1A1 and CYP2B1/2.204
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Discussion
Cancer remains one of the leading causes of death in the 
human population worldwide. The new trend of healthy 
lifestyle together with an increasing consumption of dietary 
supplements containing i.e. flavonoids evoke concerns 
regarding their unlimited consumption, as their side effects 
are not sufficiently known. Chemopreventive compounds 
are added to dietary supplements mainly for their potential 
health-beneficial activities. Flavonoids have the potential 
to modulate the activity of cytochromes P450, mainly 
CYP1A subfamily. Unfortunately, CYP1A1 and CYP1A2 
are involved in the activation of food and environmental 
carcinogens. Thus, the intake of CYP1A inducers might 
increase the human risk of cancer development.
The gastrointestinal tract is the site exposed to exogenous 
compounds of food or orally delivered drugs, therefore, the 
present study is focused on the effects of flavonoids on CYPs 
in the two organs highly exposed to xenobiotics, liver and 
small intestine of rat model organism.
To simulate real human intake of flavonoids, rats were 
treated p.o. by gastric gavages with the tested compounds 
for 5 consecutive days. In this study, we demonstrated that 
tested flavonoids, as one of the main components of dietary 
supplements, induced procarcinogen activating enzymes, 
CYP1A/2 and CYP2B1/2, in liver and small intestine.
In rat liver, based on determined protein level and spe-
cific enzyme actvities, isoquercitrin was the most efficient 
inducer of CYP1A1 and CYP1A2. On the other hand, 
aglycone quercetin had no effect either on the protein level 
or on EROD, which is in accordance with the results from 
Canivenc et al. (1996). Contrary to that, it was observed that 
quercetin caused a concentration-dependent increase of 
CYP1A1 mRNA in MCF7 cells (Ciolino et al., 1999). A study 
with commercial herbal supplement FastOne™ showed an 
increase of both EROD activity and protein level of CYP1A2, 
and thus suggests that intake of the herbal supplement may 
increase the risk of colorectal cancer in humans with the 
rapid NAT2 phenotype (Ryu and Chung, 2003). 
The same induction pattern as in liver was observed in 
small intestine; the highest increase of EROD measured 
in the middle part of small intestine and protein level of 
CYP1A1 was caused by isoquercitrin. On the contrary , 
quercetin increased PROD activity in all three parts of 
small intestine and induced CYP2B1 in proximal and 
middle parts. All the tested compounds caused an increase 
of PROD, compared to untreated rats, in the distal part 
of small intestine but CYP2B1/2 was not detected, thus it 
seems necessary to further investigate the effects of flavo-
noids on CYPs in small intestine.
The different effects of tested flavonoids on CYP 
expression and activities in small inestine and liver could be 
explained by the diverse bioavailability of particular flavo-
noids, which involve rate of transport to lumen, conjugation 
or further metabolism. Moreover, different inductive effects 
of flavonoid glycosides (isoquercitrin, rutin) and aglycone 
(quercetin) confirmed the complexity of the delivery pro-
cess from the administration site to the target organs.
In conclusion, we have demonstrated different effects of 
flavonoids on xenobiotic-metabolizing enzymes in rat liver 
and small intestine. Therefore, this study indicates that the 
consumption of dietary supplements containing flavonoids 
without any limitation should be carefully considered. 
Moreover, we confirmed that the absorption and metabo-
lism of flavonoids depend on the presence and type of sugar 
linked to aglycone.
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